Opaleye Management Inc.'s Form 4 filing
TELA Bio, Inc. (TELA) · filed Nov 4, 2022
- Accession no.
- 0001493152-22-030666
- Filed
- Nov 4, 2022
- Trade date
- Nov 3, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $158.2K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 3, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +19,000 | $7.81F3 | +$148,390 | 1,948,000 | Indirect | |
| Nov 3, 2022 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,262 | $7.81F3 | +$9,856.22 | 124,813 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $7.76 to $7.85; the price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased.
Referenced by the price of 2 transactions in Table I.